PubMed COVID-19 Clinical Care

No abstract

Objective: With the increasing incidents of discrimination toward Asian and Asian Americans (A/AA) in the United States amid the COVID-19 pandemic, this study explored A/AA university students' lived experiences of discrimination during this time and

CONCLUSIONS: Our findings provide guidance for health facilities and to design and implement future mHealth apps to help treat adolescent depression.

Letter to the Editor.

CONCLUSIONS: Within a large national cohort of hospitalized pregnant people, we found that the risk of some adverse delivery outcomes was elevated in people with COVID-19 with and without viral pneumonia, with much higher risks in the group with

CONCLUSION: It is safe and effective for patients with CLD to complete basic and booster immunization with SARS-CoV-2 vaccines. After booster immunization, the immune response of patients with CLD was further improved and the durability of the SARS

According to recent epidemiological analysis, the percentage of world population infected with COVID-19 by end of December 2020 is approximately 12.56%¹. COVID induced acute care and ICU hospitalization rates are around 9.22 (95% CI: 18.73-19.51)

CONCLUSIONS: Our findings suggest that three-drug combination may decrease LOS in severe COVID-19 patients when compared to two-drug therapy. However, the trend was not supported by statistical analysis. Remdesivir may not be clinically beneficial

Lipids may influence cellular penetrance by pathogens and the immune response that they evoke. Here we find a broad based lipidomic storm driven predominantly by secretory (s) phospholipase A (2) (sPLA (2) ) dependent eicosanoid production occurs in

BackgroundThe majority of allied health services are delivered by small, private practices in the primary care setting with limited government funding. During the coronavirus disease 2019 (COVID-19) lockdowns these practices were subject to the same